12.79
+0.79
+(6.58%)
At close: February 18 at 4:00:00 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.69M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HOMCY CHARLES J Director | -- | Indirect | -- | Feb 3, 2025 |
| LIM JONATHAN E Director | -- | Indirect | -- | Feb 3, 2025 |
| THIRD ROCK VENTURES IV, L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Feb 3, 2025 |
Related Tickers
MTSR Metsera, Inc.
32.08
+4.91%
SION Sionna Therapeutics, Inc.
20.04
+0.05%
ALMS Alumis Inc.
5.06
-2.88%
SEPN Septerna, Inc.
6.87
-46.99%
AARD Aardvark Therapeutics, Inc. Common Stock
13.56
+1.95%
AAPG Ascentage Pharma Group Internat
18.51
+1.48%
BCAX Bicara Therapeutics Inc.
13.09
-2.89%
UPB Upstream Bio, Inc.
8.40
+10.53%
RAPP Rapport Therapeutics, Inc.
14.04
-11.70%
MBX MBX Biosciences, Inc.
10.90
+4.71%